tiprankstipranks
Trending News
More News >
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Financial Statements

Compare
14 Followers

NATCO Pharma Limited Financial Overview

NATCO Pharma Limited's market cap is currently ₹159.47B. The company's EPS TTM is ₹29; its P/E ratio is 10.36; and it has a dividend yield of 0.57%. NATCO Pharma Limited is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹5.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 44.32B₹ 40.02B₹ 27.09B₹ 19.46B₹ 20.56B
Gross Profit₹ 37.05B₹ 32.53B₹ 20.54B₹ 13.62B₹ 15.24B
Operating Income₹ 30.00B₹ 25.96B₹ 14.92B₹ 6.93B₹ 9.31B
EBITDA₹ 21.44B₹ 17.51B₹ 9.67B₹ 2.60B₹ 6.07B
Net Income₹ 18.85B₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B
Balance Sheet
Cash & Short-Term Investments₹ 24.97B₹ 17.78B₹ 11.25B₹ 7.60B₹ 8.18B
Total Assets₹ 86.31B₹ 69.06B₹ 56.57B₹ 51.09B₹ 47.92B
Total Debt₹ 2.79B₹ 3.86B₹ 1.76B₹ 4.32B₹ 2.84B
Net Debt₹ -18.97B₹ 3.16B₹ 348.00M₹ 3.21B₹ 2.58B
Total Liabilities₹ 10.19B₹ 10.53B₹ -34.80B₹ 8.46B₹ 6.68B
Stockholders' Equity₹ 76.07B₹ 58.53B₹ 48.74B₹ 42.64B₹ 41.22B
Cash Flow
Free Cash Flow₹ 14.28B₹ 8.72B₹ 6.43B₹ -1.96B₹ 442.00M
Operating Cash Flow₹ 16.97B₹ 12.12B₹ 8.49B₹ 465.00M₹ 2.99B
Investing Cash Flow₹ -14.14B₹ -10.33B₹ -4.77B₹ -53.00M₹ -1.03B
Financing Cash Flow₹ -2.11B₹ -2.47B₹ -3.63B₹ 348.00M₹ -1.86B
Currency in INR

NATCO Pharma Limited Earnings and Revenue History

NATCO Pharma Limited Debt to Assets

NATCO Pharma Limited Cash Flow

NATCO Pharma Limited Forecast EPS vs Actual EPS